Elizabeth A. Brem

Elizabeth A. Brem, MD is an Assistant Professor at the Department of Medicine, Division of Hematology/Oncology, University of California, Irvine School of Medicine. She is triple-board certified in Hematology, Medical Oncology, and Internal Medicine, with a clinical focus on lymphoma and hematologic malignancies.

• Education:
  • Medical Degree, University at Buffalo Jacobs School of Medicine and Biomedical Sciences
  • Residency, Beth Israel Deaconess Medical Center
  • Fellowship, Harvard Medical School
• Research Interests:
  • Lymphoma biology
  • Apoptosis regulation via BCL-2 family proteins
  • Therapeutic resistance mechanisms
  • Innovative clinical trial design
• Scientific Affiliations:
  • Alpha Omega Alpha Honor Medical Society
  • American Society of Hematology (ASH)
  • American Society of Clinical Oncology (ASCO)
  • University of California Hematologic Malignancies Consortium

Dr. Brem currently serves as Principal Investigator in multiple lymphoma clinical trials, including studies involving CAR T-cell therapy, bispecific antibodies, and observational effectiveness research.